Dulcolax 5mg Coated Tablets, 10's

DulcolaxSKU: 721549013

Price:
Sale priceR 40.90

The product images shown are for illustration purposes only.

Shipping - Read more here:

  • FREE delivery for metropolitan orders R600+
  • FREE in-store collections (Crossings store in Nelspruit only)
  • R20 delivery for selected areas
  • R75 delivery for metropolitan orders below R600 (2-3 working days)
  • R150 delivery in non-metropolitan areas (3-7 working days)

Description

Dulcolax Laxative Tablets (5 mg) is a mild laxative that provides the relief of occasional constipation.

Pack size: 10 coated tablets

Usage instructions:
1- 3 tablets as a single daily dose. Children 6 -12 years: 1 tablet as a single daily dose. The tablets should be swallowed whole. Dosage and directions for use: Unless otherwise prescribed by your doctor, the following dosages are recommended: Tablets: Bowel movement is generally produced within 6 to 12 hours. Adults and children 12 years and over: 1-3 tablets as a single daily dose. Children 6 years to under 12 years: 1 tablet as a single daily dose. The tablets should be swallowed whole with adequate fluid. The tablets should be taken at night to produce evacuation the following morning. Do not give to children under 6 years of age or to persons who cannot swallow without chewing, unless directed by a doctor. Do not take this product within one hour after taking an antacid or milk.

Storage instructions: Store below 30 degrees C.

Warnings:
Keep out of reach of children. This medicine should not be used in the presence of abdominal pain, nausea or vomiting. Frequent or prolonged use of this preparation may result in dependence on laxatives and loss of normal bowel function. If you have noticed a sudden change in bowel habits that has persisted for a period of greater than 2 weeks, consult a doctor before using the laxative. This product should not be used for a period longer than one week, unless directed by a doctor. If a laxative is needed every day, the cause of constipation should be investigated. Rectal bleeding or failure to have a bowel movement after use of a laxative, may indicate a serious condition. Discontinue use and consult a doctor. Interactions: The concomitant use of diuretics or adreno-corticosteroids may increase the risk of electrolyte imbalance if excessive doses of Dulcolax are taken. Electrolyte imbalance may lead to increased sensitivity to cardiac glycosides. Pregnancy and lactation: Safety in pregnancy and lactation has not been established. Side- effects and special precautions: Side-effects: Dulcolax may cause abdominal discomfort, diarrhoea, abdominal pain and abdominal cramps. Allergic reactions, including isolated cases of angio-oedema and anaphylactoid reactions have been reported in association with the administration of Dulcolax. Special precautions: Prolonged use may lead to diarrhoea with excessive loss of water and electrolytes, particularly potassium, and possible atonic non-functioning colon. Dizziness and/or syncope have been reported in patients who have taken Dulcolax. The details available for these cases suggest that the events would be consistent with defecation syncope (or syncope attributable to straining at stool), or with a vasovagal response to abdominal pain, which may be related to the constipation that prompted the patients in question to resort to the use of laxatives and not necessarily to the administration of Dulcolax itself. Care should be taken in patients with inflammatory bowel disease. Children should not take Dulcolax without medical advice. Known symptoms of overdosage and particulars of its treatment: Symptoms: If high doses are taken watery stools (diarrhoea), abdominal cramps and a clinically significant loss of potassium and other electrolytes can occur. Chronic overdose with Dulcolax may cause chronic diarrhoea, abdominal pain, hypokalaemia, secondary hyperaldosteronism and renal calculi. Renal tubular damage, metabolic alkalosis and muscle weakness secondary to hypokalaemia have also been described in association with chronic laxative abuse. Therapy: Within a short period of time after ingestion of oral dosage forms of Dulcolax, absorption can be minimised or prevented by inducing vomiting or gastric lavage. Replacement of fluids and correction of electrolyte imbalance may be required. This is especially important in the elderly and the young.

Ingredients: Each coated tablet contains Bisacodyl 5mg. Contains sugar.

Recently viewed